SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '1y4j'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID
Hit
Macromolecule
Res.
Matches
Interface HETATM RMSD Dali
Z-score
Seq.
Identity (%)
View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1BDW_B_DVAB6_0
(GRAMICIDIN A)
1y4j SULFATASE MODIFYING
FACTOR 2

(Homo
sapiens)
3 / 3 TRP A 126
ALA A  87
VAL A 147
None
0.88A 1bdwA-1y4jA:
undetectable
1bdwB-1y4jA:
undetectable
1bdwA-1y4jA:
5.77
1bdwB-1y4jA:
5.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1OM5_A_H4BA760_1
(NITRIC-OXIDE
SYNTHASE, BRAIN)
1y4j SULFATASE MODIFYING
FACTOR 2

(Homo
sapiens)
4 / 8 TRP A 235
TRP A 169
TRP A 237
GLU A 236
None
None
None
CA  A1004 (-3.6A)
1.17A 1om5A-1y4jA:
undetectable
1om5B-1y4jA:
undetectable
1om5A-1y4jA:
20.94
1om5B-1y4jA:
20.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1RS6_B_H4BB761_1
(NITRIC-OXIDE
SYNTHASE, BRAIN)
1y4j SULFATASE MODIFYING
FACTOR 2

(Homo
sapiens)
4 / 8 TRP A 169
TRP A 237
GLU A 236
TRP A 235
None
None
CA  A1004 (-3.6A)
None
1.25A 1rs6A-1y4jA:
undetectable
1rs6B-1y4jA:
undetectable
1rs6A-1y4jA:
20.94
1rs6B-1y4jA:
20.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2G6H_A_H4BA760_1
(NITRIC-OXIDE
SYNTHASE, BRAIN)
1y4j SULFATASE MODIFYING
FACTOR 2

(Homo
sapiens)
4 / 8 TRP A 235
TRP A 169
TRP A 237
GLU A 236
None
None
None
CA  A1004 (-3.6A)
1.17A 2g6hA-1y4jA:
undetectable
2g6hB-1y4jA:
undetectable
2g6hA-1y4jA:
20.43
2g6hB-1y4jA:
20.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2QR2_B_VK3B236_1
(PROTEIN (QUINONE
REDUCTASE TYPE 2))
1y4j SULFATASE MODIFYING
FACTOR 2

(Homo
sapiens)
4 / 5 TRP A 257
GLY A 203
PHE A  99
PHE A  96
None
1.02A 2qr2A-1y4jA:
undetectable
2qr2B-1y4jA:
undetectable
2qr2A-1y4jA:
20.20
2qr2B-1y4jA:
20.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2Y00_B_Y00B601_2
(BETA-1 ADRENERGIC
RECEPTOR)
1y4j SULFATASE MODIFYING
FACTOR 2

(Homo
sapiens)
3 / 3 VAL A 271
ASN A 186
TRP A 187
None
1.12A 2y00B-1y4jA:
undetectable
2y00B-1y4jA:
20.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3B3P_B_H4BB760_1
(NITRIC-OXIDE
SYNTHASE)
1y4j SULFATASE MODIFYING
FACTOR 2

(Homo
sapiens)
4 / 8 TRP A 169
TRP A 237
GLU A 236
TRP A 235
None
None
CA  A1004 (-3.6A)
None
1.22A 3b3pA-1y4jA:
undetectable
3b3pB-1y4jA:
undetectable
3b3pA-1y4jA:
20.79
3b3pB-1y4jA:
20.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3D4S_A_TIMA401_2
(BETA-2 ADRENERGIC
RECEPTOR/T4-LYSOZYME
CHIMERA)
1y4j SULFATASE MODIFYING
FACTOR 2

(Homo
sapiens)
3 / 3 THR A 238
SER A 240
PHE A  62
None
0.89A 3d4sA-1y4jA:
undetectable
3d4sA-1y4jA:
22.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3E7G_D_H4BD3902_1
(NITRIC OXIDE
SYNTHASE, INDUCIBLE)
1y4j SULFATASE MODIFYING
FACTOR 2

(Homo
sapiens)
4 / 8 TRP A 169
TRP A 237
GLU A 236
TRP A 235
None
None
CA  A1004 (-3.6A)
None
1.12A 3e7gC-1y4jA:
undetectable
3e7gD-1y4jA:
undetectable
3e7gC-1y4jA:
20.44
3e7gD-1y4jA:
20.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NLQ_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
1y4j SULFATASE MODIFYING
FACTOR 2

(Homo
sapiens)
4 / 8 TRP A 235
TRP A 169
TRP A 237
GLU A 236
None
None
None
CA  A1004 (-3.6A)
1.18A 3nlqA-1y4jA:
undetectable
3nlqB-1y4jA:
undetectable
3nlqA-1y4jA:
20.47
3nlqB-1y4jA:
20.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3SAN_A_ZMRA901_1
(NEURAMINIDASE)
1y4j SULFATASE MODIFYING
FACTOR 2

(Homo
sapiens)
5 / 12 ARG A  55
GLU A 167
ALA A 173
GLU A 166
ARG A 253
None
1.43A 3sanA-1y4jA:
undetectable
3sanA-1y4jA:
19.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3SAN_B_ZMRB901_1
(NEURAMINIDASE)
1y4j SULFATASE MODIFYING
FACTOR 2

(Homo
sapiens)
5 / 12 ARG A  55
GLU A 167
ALA A 173
GLU A 166
ARG A 253
None
1.43A 3sanB-1y4jA:
undetectable
3sanB-1y4jA:
19.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TIC_B_ZMRB1002_1
(NEURAMINIDASE)
1y4j SULFATASE MODIFYING
FACTOR 2

(Homo
sapiens)
5 / 12 ARG A  55
GLU A 167
ALA A 173
GLU A 166
ARG A 253
None
1.44A 3ticB-1y4jA:
undetectable
3ticB-1y4jA:
19.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4I00_A_ZMRA509_1
(NEURAMINIDASE)
1y4j SULFATASE MODIFYING
FACTOR 2

(Homo
sapiens)
5 / 12 ARG A  55
GLU A 167
ALA A 173
GLU A 166
ARG A 253
None
1.43A 4i00A-1y4jA:
undetectable
4i00A-1y4jA:
20.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4JJK_A_FOLA601_0
(FORMATE--TETRAHYDROF
OLATE LIGASE)
1y4j SULFATASE MODIFYING
FACTOR 2

(Homo
sapiens)
4 / 8 ALA A 172
GLU A 236
LEU A 230
LEU A 227
None
CA  A1004 (-3.6A)
None
None
0.92A 4jjkA-1y4jA:
undetectable
4jjkA-1y4jA:
20.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MWR_A_ZMRA513_1
(NEURAMINIDASE)
1y4j SULFATASE MODIFYING
FACTOR 2

(Homo
sapiens)
5 / 12 ARG A  55
GLU A 167
ALA A 173
GLU A 166
ARG A 253
None
1.45A 4mwrA-1y4jA:
undetectable
4mwrA-1y4jA:
20.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4PGF_B_ADNB502_2
(ADENOSYLHOMOCYSTEINA
SE)
1y4j SULFATASE MODIFYING
FACTOR 2

(Homo
sapiens)
4 / 5 THR A 238
THR A 273
HIS A 267
ASN A 285
None
1.42A 4pgfB-1y4jA:
undetectable
4pgfB-1y4jA:
20.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QVN_K_BO2K301_1
(PROTEASOME SUBUNIT
BETA TYPE-5
PROTEASOME SUBUNIT
BETA TYPE-6)
1y4j SULFATASE MODIFYING
FACTOR 2

(Homo
sapiens)
5 / 9 THR A 238
ALA A 239
VAL A  69
GLY A 287
ALA A 152
None
1.05A 4qvnK-1y4jA:
undetectable
4qvnL-1y4jA:
undetectable
4qvnK-1y4jA:
22.60
4qvnL-1y4jA:
20.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QVN_Y_BO2Y301_1
(PROTEASOME SUBUNIT
BETA TYPE-5
PROTEASOME SUBUNIT
BETA TYPE-6)
1y4j SULFATASE MODIFYING
FACTOR 2

(Homo
sapiens)
5 / 9 THR A 238
ALA A 239
VAL A  69
GLY A 287
ALA A 152
None
1.05A 4qvnY-1y4jA:
undetectable
4qvnZ-1y4jA:
undetectable
4qvnY-1y4jA:
22.60
4qvnZ-1y4jA:
20.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UCH_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
1y4j SULFATASE MODIFYING
FACTOR 2

(Homo
sapiens)
4 / 8 TRP A 169
TRP A 237
GLU A 236
TRP A 235
None
None
CA  A1004 (-3.6A)
None
1.18A 4uchA-1y4jA:
undetectable
4uchB-1y4jA:
undetectable
4uchA-1y4jA:
21.26
4uchB-1y4jA:
21.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4V3W_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
1y4j SULFATASE MODIFYING
FACTOR 2

(Homo
sapiens)
4 / 7 TRP A 169
TRP A 237
GLU A 236
TRP A 235
None
None
CA  A1004 (-3.6A)
None
1.13A 4v3wA-1y4jA:
undetectable
4v3wB-1y4jA:
undetectable
4v3wA-1y4jA:
20.79
4v3wB-1y4jA:
20.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UO9_B_H4BB502_1
(NITRIC OXIDE
SYNTHASE,
ENDOTHELIAL)
1y4j SULFATASE MODIFYING
FACTOR 2

(Homo
sapiens)
4 / 7 TRP A 169
TRP A 237
GLU A 236
TRP A 235
None
None
CA  A1004 (-3.6A)
None
1.18A 5uo9A-1y4jA:
0.0
5uo9B-1y4jA:
0.0
5uo9A-1y4jA:
20.69
5uo9B-1y4jA:
20.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UO9_D_H4BD502_1
(NITRIC OXIDE
SYNTHASE,
ENDOTHELIAL)
1y4j SULFATASE MODIFYING
FACTOR 2

(Homo
sapiens)
4 / 7 TRP A 169
TRP A 237
GLU A 236
TRP A 235
None
None
CA  A1004 (-3.6A)
None
1.17A 5uo9C-1y4jA:
0.0
5uo9D-1y4jA:
undetectable
5uo9C-1y4jA:
20.69
5uo9D-1y4jA:
20.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VV9_A_H4BA502_1
(NITRIC OXIDE
SYNTHASE,
ENDOTHELIAL)
1y4j SULFATASE MODIFYING
FACTOR 2

(Homo
sapiens)
4 / 7 TRP A 235
TRP A 169
TRP A 237
GLU A 236
None
None
None
CA  A1004 (-3.6A)
1.11A 5vv9A-1y4jA:
0.0
5vv9B-1y4jA:
0.0
5vv9A-1y4jA:
20.31
5vv9B-1y4jA:
20.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VVA_A_H4BA502_1
(NITRIC OXIDE
SYNTHASE,
ENDOTHELIAL)
1y4j SULFATASE MODIFYING
FACTOR 2

(Homo
sapiens)
4 / 7 TRP A 235
TRP A 169
TRP A 237
GLU A 236
None
None
None
CA  A1004 (-3.6A)
1.11A 5vvaA-1y4jA:
0.0
5vvaB-1y4jA:
0.0
5vvaA-1y4jA:
20.31
5vvaB-1y4jA:
20.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VVD_B_H4BB502_1
(NITRIC OXIDE
SYNTHASE,
ENDOTHELIAL)
1y4j SULFATASE MODIFYING
FACTOR 2

(Homo
sapiens)
4 / 7 TRP A 169
TRP A 237
GLU A 236
TRP A 235
None
None
CA  A1004 (-3.6A)
None
1.13A 5vvdA-1y4jA:
0.0
5vvdB-1y4jA:
0.0
5vvdA-1y4jA:
20.69
5vvdB-1y4jA:
20.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AUU_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
1y4j SULFATASE MODIFYING
FACTOR 2

(Homo
sapiens)
4 / 7 TRP A 235
TRP A 169
TRP A 237
GLU A 236
None
None
None
CA  A1004 (-3.6A)
1.11A 6auuA-1y4jA:
undetectable
6auuB-1y4jA:
undetectable
6auuA-1y4jA:
17.78
6auuB-1y4jA:
17.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AV6_B_H4BB503_1
(NITRIC OXIDE
SYNTHASE,
ENDOTHELIAL)
1y4j SULFATASE MODIFYING
FACTOR 2

(Homo
sapiens)
4 / 7 TRP A 169
TRP A 237
GLU A 236
TRP A 235
None
None
CA  A1004 (-3.6A)
None
1.14A 6av6A-1y4jA:
0.0
6av6B-1y4jA:
0.0
6av6A-1y4jA:
13.38
6av6B-1y4jA:
13.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6CIE_B_H4BB502_0
(NITRIC OXIDE
SYNTHASE,
ENDOTHELIAL)
1y4j SULFATASE MODIFYING
FACTOR 2

(Homo
sapiens)
4 / 7 TRP A 169
TRP A 237
GLU A 236
TRP A 235
None
None
CA  A1004 (-3.6A)
None
1.11A 6cieA-1y4jA:
0.0
6cieB-1y4jA:
0.0
6cieA-1y4jA:
13.38
6cieB-1y4jA:
13.38